These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26891835)

  • 1. Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents.
    Hukkinen M; Pakarinen MP; Merras-Salmio L; Koivusalo A; Rintala R; Kolho KL
    J Pediatr Surg; 2016 Sep; 51(9):1467-72. PubMed ID: 26891835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
    Verdejo C; Hervías D; Roncero Ó; Arias Á; Bouhmidi A; Lorente R; Salueña I; Lucendo AJ
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1521-1527. PubMed ID: 30303822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 May; 22(5):1086-94. PubMed ID: 26818420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease.
    Veyre F; Boschetti G; Meunier C; Cuerq C; Gay C; Charlois AL; Duclaux-Loras R; Danion P; Cotte E; Kepenekian V; Mialon A; Faure M; Roblin X; Flourie B; Nancey S
    Dig Dis Sci; 2021 Dec; 66(12):4429-4435. PubMed ID: 33387123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
    Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.
    Cerrillo E; Moret I; Iborra M; Pamies J; Hervás D; Tortosa L; Sáez-González E; Nos P; Beltrán B
    Inflamm Bowel Dis; 2019 Sep; 25(10):1681-1691. PubMed ID: 30925193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Calprotectin and Modified Rutgeerts Score.
    Lopes S; Andrade P; Afonso J; Rodrigues-Pinto E; Dias CC; Macedo G; Magro F
    Inflamm Bowel Dis; 2016 Sep; 22(9):2173-81. PubMed ID: 27482974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
    Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
    Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
    J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease.
    Garcia-Planella E; Mañosa M; Cabré E; Marín L; Gordillo J; Zabana Y; Boix J; Sáinz S; Domènech E
    Inflamm Bowel Dis; 2016 Dec; 22(12):2879-2885. PubMed ID: 27824646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures.
    Lopes S; Andrade P; Rodrigues-Pinto E; Afonso J; Macedo G; Magro F
    World J Gastroenterol; 2017 Sep; 23(35):6482-6490. PubMed ID: 29085198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
    World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease.
    Boube M; Laharie D; Nancey S; Hebuterne X; Fumery M; Pariente B; Roblin X; Peyrin-Biroulet L; Minet-Quinard R; Pereira B; Bommelaer G; Buisson A;
    Dig Liver Dis; 2020 Jul; 52(7):740-744. PubMed ID: 32444250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
    Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease.
    Pous-Serrano S; Frasson M; Cerrillo E; Beltrán B; Iborra M; Hervás D; García-Granero E; Nos P
    J Surg Res; 2017 Jun; 213():290-297. PubMed ID: 28601328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study.
    Ye L; Chen BQ; Wang SD; Shi H; Yang Z; Wang FY
    Scand J Gastroenterol; 2017 Oct; 52(10):1113-1119. PubMed ID: 28675068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.